Progress in research and treatment of immune checkpoints in breast cancer
Xinyi Zhang, Jie Wang, Kaiyuan Zhou
Breast cancer is the most common malignant tumor among women often involving the toxicity of conventional chemotherapy alongside organ-specific side effects. As immunotherapeutic agents in anti-tumor, new immune checkpoints are constantly being dug and discovered. The role of immune checkpoint inhibitors in the process of tumor immune evasion has assumed increasing significance. Currently, clinic...
REVIEW | Published: 08 Apr 2024
Asia-Pacific Journal of Oncology, Articles, Online First